Education
About Us
Working with TipRanks
Follow Us
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
Paradigm Biopharmaceuticals (PBIGF) Ownership Overview
4.75% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
0.01% ETFs
95.21% Public Companies and
Individual Investors
The ownership structure of Paradigm Biopharmaceuticals (PBIGF) stock is a mix of institutional, retail, and individual investors. Approximately 0.04% of the company’s stock is owned by Institutional Investors, 4.75% is owned by Insiders, and 95.21% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,880,015 | Insider | 4.75% | 3,967,203 | |
| 105,692 | Institution | 0.02% | 20,081 | |
| 54,522 | Institution | 0.01% | 10,359 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 105,692 | Institution | 0.02% | 20,081 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Paradigm Biopharmaceuticals Ltd. (PBIGF)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 4.75% is held by insiders, and 95.21% is held by retail investors.
What percentage of Paradigm Biopharmaceuticals Ltd. (PBIGF) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Paradigm Biopharmaceuticals Ltd. (PBIGF) stock is held by institutional investors.
What percentage of Paradigm Biopharmaceuticals Ltd. (PBIGF) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.21% of Paradigm Biopharmaceuticals Ltd. (PBIGF) stock is held by retail investors.
Who owns the most shares of Paradigm Biopharmaceuticals Ltd. (PBIGF)?
Paul Rennie owns the most shares of Paradigm Biopharmaceuticals Ltd. (PBIGF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.